Cargando…
Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319331/ https://www.ncbi.nlm.nih.gov/pubmed/34321457 http://dx.doi.org/10.1038/s41392-021-00706-0 |
| _version_ | 1783730423458693120 |
|---|---|
| author | Charo, Jehad Gomes, Bruno |
| author_facet | Charo, Jehad Gomes, Bruno |
| author_sort | Charo, Jehad |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8319331 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83193312021-08-02 Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells Charo, Jehad Gomes, Bruno Signal Transduct Target Ther Research Highlight Nature Publishing Group UK 2021-07-28 /pmc/articles/PMC8319331/ /pubmed/34321457 http://dx.doi.org/10.1038/s41392-021-00706-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Research Highlight Charo, Jehad Gomes, Bruno Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells |
| title | Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells |
| title_full | Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells |
| title_fullStr | Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells |
| title_full_unstemmed | Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells |
| title_short | Doubling down with CAR-T cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells |
| title_sort | doubling down with car-t cell cancer immunotherapy: a two-step recognition circuit enables discrimination between target antigen high and low cancer cells |
| topic | Research Highlight |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319331/ https://www.ncbi.nlm.nih.gov/pubmed/34321457 http://dx.doi.org/10.1038/s41392-021-00706-0 |
| work_keys_str_mv | AT charojehad doublingdownwithcartcellcancerimmunotherapyatwosteprecognitioncircuitenablesdiscriminationbetweentargetantigenhighandlowcancercells AT gomesbruno doublingdownwithcartcellcancerimmunotherapyatwosteprecognitioncircuitenablesdiscriminationbetweentargetantigenhighandlowcancercells |